Figure 2

Correlation between ficolin-3 levels with severity and outcome of stroke and size of infarct. Panel A: Negative correlation between serum ficolin-3 levels in follow-up (FU) samples and the severity of stroke as assessed by the NIH stroke scale at admission in 65 patients with ischemic stroke. Patients with unfavorable (≥ 16) vs. favorable (< 16) NIH scale were compared. P value of Mann-Whitney test is indicated. Panel B: Negative correlation between serum ficolin-3 levels in follow-up samples and the size of cerebral infarct as assessed by the S100β level in follow-up samples. Spearman's correlation coefficient and its significance is indicated. Panel C: Positive correlation between serum CRP levels in follow-up samples and the severity of stroke as assessed by the NIH scale at admission in 65 patients with ischemic stroke. Patients with unfavorable (≥ 16) vs. favorable (< 16) NIH scale were compared. P value of Mann-Whitney test is indicated. Panel D: No significant correlation between serum CRP levels in follow-up samples and the size of cerebral infarct as assessed by the S100β level in follow-up samples. Spearman's correlation coefficient and its significance is indicated.